Thursday, 5 December 2019

Sage's oral depression therapy fails in late-stage trial

Sage Therapeutics Inc said on Thursday its experimental drug failed to meet the main goal of reducing symptoms in patients with severe depression in a late-stage study.


No comments:

Post a Comment